Biosimilar medicines in community pharmacy

The expanding use of biosimilar medicines in Australia is expected to deliver significant savings, which can be reinvested back into the Australian healthcare system.

This session will focus on biosimilar medicine use in a community pharmacy setting and examine topics including what are biosimilars, the pharmacist’s role in the uptake of biosimilars in Australia and the importance of patient choice.

The session will also explore how pharmacists can utilise the suite of resources made available by the Department of Health and GBMA Education.

When: 12.05 pm – 12.50 pm, Friday 6 September

Proudly sponsored by:

 

 

Stay up to date with Pharmacy Connect 2019! 
Newsletter: Subscribe to the newsletter here
Facebook: Follow @PharmacyConnectConference
Twitter: Follow @PharmConnectAus